UBS Group’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-62,129
| Closed | -$26.1K | – | 11439 |
|
|
2022
Q4 | $26.1K | Buy |
62,129
+26,753
| +76% | +$14.4K | ﹤0.01% | 7384 |
|
|
2022
Q3 | $28K | Buy |
35,376
+4,078
| +13% | +$4.29K | ﹤0.01% | 6973 |
|
|
2022
Q2 | $40K | Sell |
31,298
-6,239
| -17% | -$8.22K | ﹤0.01% | 6111 |
|
|
2022
Q1 | $53K | Buy |
37,537
+25,048
| +201% | +$53.6K | ﹤0.01% | 6449 |
|
|
2021
Q4 | $34K | Buy |
12,489
+12,389
| +12,389% | +$45.7K | ﹤0.01% | 7287 |
|
|
2021
Q3 | $0 | Sell |
100
-2,065
| -95% | -$15.1K | ﹤0.01% | 10426 |
|
|
2021
Q2 | $17K | Sell |
2,165
-14,482
| -87% | -$121K | ﹤0.01% | 7539 |
|
|
2021
Q1 | $133K | Sell |
16,647
-6,880
| -29% | -$64.1K | ﹤0.01% | 5741 |
|
|
2020
Q4 | $211K | Buy |
23,527
+11,451
| +95% | +$95.2K | ﹤0.01% | 5213 |
|
|
2020
Q3 | $91K | Sell |
12,076
-2,929
| -20% | -$20.3K | ﹤0.01% | 5247 |
|
|
2020
Q2 | $96K | Sell |
15,005
-6,688
| -31% | -$44.7K | ﹤0.01% | 5349 |
|
|
2020
Q1 | $161K | Sell |
21,693
-22,309
| -51% | -$173K | ﹤0.01% | 4893 |
|
|
2019
Q4 | $397K | Buy |
44,002
+14,519
| +49% | +$122K | ﹤0.01% | 5048 |
|
|
2019
Q3 | $221K | Buy |
29,483
+18,234
| +162% | +$102K | ﹤0.01% | 5171 |
|
|
2019
Q2 | $58K | Buy |
11,249
+7,517
| +201% | +$49K | ﹤0.01% | 5791 |
|
|
2019
Q1 | $32K | Sell |
3,732
-13,128
| -78% | -$94.5K | ﹤0.01% | 5904 |
|
|
2018
Q4 | $72K | Sell |
16,860
-343,038
| -95% | -$3.03M | ﹤0.01% | 5816 |
|
|
2018
Q3 | $5.24M | Sell |
359,898
-996
| -0.3% | -$16.5K | ﹤0.01% | 2306 |
|
|
2018
Q2 | $6.71M | Buy |
360,894
+5,332
| +1% | +$96.5K | ﹤0.01% | 2088 |
|
|
2018
Q1 | $6.19M | Buy |
355,562
+166,532
| +88% | +$2.94M | ﹤0.01% | 2114 |
|
|
2017
Q4 | $3.19M | Buy |
189,030
+31,492
| +20% | +$512K | ﹤0.01% | 2774 |
|
|
2017
Q3 | $2.48M | Buy |
157,538
+154,664
| +5,381% | +$2.21M | ﹤0.01% | 2928 |
|
|
2017
Q2 | $38K | Buy |
2,874
+1,446
| +101% | +$19K | ﹤0.01% | 5856 |
|
|
2017
Q1 | $17K | Sell |
1,428
-4,350
| -75% | -$52.2K | ﹤0.01% | 6280 |
|
|
2016
Q4 | $75K | Buy |
5,778
+943
| +20% | +$10.9K | ﹤0.01% | 5506 |
|
|
2016
Q3 | $54K | Sell |
4,835
-3,864
| -44% | -$46.5K | ﹤0.01% | 5455 |
|
|
2016
Q2 | $105K | Buy |
8,699
+6,551
| +305% | +$77.2K | ﹤0.01% | 4997 |
|
|
2016
Q1 | $28K | Buy |
2,148
+25
| +1% | +$355 | ﹤0.01% | 5952 |
|
|
2015
Q4 | $37K | Buy |
2,123
+122
| +6% | +$2.2K | ﹤0.01% | 6125 |
|
|
2015
Q3 | $29K | Sell |
2,001
-435
| -18% | -$7.61K | ﹤0.01% | 6337 |
|
|
2015
Q2 | $52K | Buy |
2,436
+195
| +9% | +$4.13K | ﹤0.01% | 5991 |
|
|
2015
Q1 | $44K | Sell |
2,241
-4,103
| -65% | -$71.1K | ﹤0.01% | 6179 |
|
|
2014
Q4 | $106K | Buy |
+6,344
| New | +$96.3K | ﹤0.01% | 5651 |
|
Other funds holding IVC
PCMI
IIM
AA
WFA
HNB
HCM
UBS Group's IVC Position: Q1 2023 in Review
UBS Group sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 62,129 shares — an estimated $26.1K sold.
UBS Group first reported a position in IVC in Q4 2014 and held it in 33 quarters. The position peaked at $6.71M in Q2 2018. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.
- UBS Group reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
- UBS Group sold 62,129 Invacare Corporation shares in Q1 2023, an estimated $26.1K.
- UBS Group first reported a position in Invacare Corporation in Q4 2014 and held it in 33 quarters.
- UBS Group's Invacare Corporation position peaked at $6.71M in Q2 2018.
- 10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.